Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.
Collaborating with ZyVersa
ZyVersa is committed to develop and commercialize novel, first-in-class drugs or biologics that optimize health outcomes and improve quality of life for patients with unmet medical needs. To achieve this, we are seeking strategic alliances and collaborations to accelerate development and maximize potential of our current pipeline candidates. We are also interested in expanding our pipeline with novel drugs or biologics that have potential to restore health and transform the lives of people with high unmet medical needs. We are actively seeking partners to accomplish this, and we would like the opportunity to speak with you.
To discuss potential partnership opportunities, contact Melda Uzbil, Senior Vice President of Corporate Development at 754-231-1691. Her e-mail address is firstname.lastname@example.org.